1. Home
  2. UBER vs GKOS Comparison

UBER vs GKOS Comparison

Compare UBER & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

UBER

Uber Technologies Inc.

HOLD

Current Price

$81.23

Market Cap

195.5B

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$116.21

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UBER
GKOS
Founded
2009
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
195.5B
5.4B
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
UBER
GKOS
Price
$81.23
$116.21
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
35
13
Target Price
$108.75
$126.38
AVG Volume (30 Days)
19.4M
694.2K
Earning Date
02-04-2026
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
286.11
N/A
EPS
7.80
N/A
Revenue
$49,610,000,000.00
$469,820,000.00
Revenue This Year
$20.62
$31.15
Revenue Next Year
$15.86
$24.15
P/E Ratio
$10.42
N/A
Revenue Growth
18.25
30.38
52 Week Low
$60.02
$73.16
52 Week High
$101.99
$163.71

Technical Indicators

Market Signals
Indicator
UBER
GKOS
Relative Strength Index (RSI) 38.56 71.98
Support Level $80.35 $115.07
Resistance Level $82.25 $117.94
Average True Range (ATR) 2.08 2.91
MACD -0.11 -0.13
Stochastic Oscillator 20.32 81.29

Price Performance

Historical Comparison
UBER
GKOS

About UBER Uber Technologies Inc.

Uber Technologies is a technology provider that matches riders with drivers, hungry people with restaurants and food couriers, and shippers with carriers. The firm's on-demand technology platform is currently utilized by traditional cars as well as autonomous vehicles, but could eventually be used for additional products and services, such as delivery via drones or electronic vehicle take-off and landing (eVTOL) technology. Uber operates in over 70 countries, with over 180 million users who order rides or food at least once a month.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: